posted by user: virtueinsightcon || 334 views || tracked by 2 users: [display]

biosimilars 2017 : 11th Biosimilars Congregation 2017

FacebookTwitterLinkedInGoogle

Link: http://www.virtueinsight.com/pharma/11th-Biosimilars-Congregation-2017/
 
When Dec 6, 2017 - Dec 6, 2017
Where Kohinoor Continental Hotel, Mumbai, Indi
Submission Deadline Dec 6, 2017
Notification Due Dec 6, 2017
Final Version Due Oct 6, 2017
Categories    pharma   biosimilars   medical
 

Call For Papers

11th Biosimilars Congregation 2017
“Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
06th December 2017, Kohinoor Continental Hotel, Mumbai, India

Virtue insight is proud to present its 11th Biosimilars Congregation on 6th December 2017 at Kohinoor Continental Hotel, Mumbai, India. Discussing strategies for biosimilar product development Indian Pharmaceutical companies have started to look at biosimilars as a lucrative sector owing to the recent regulatory approvals and revenue generating opportunities. This event will discuss commercial strategies, insights on how regulatory & approval process work in region, opportunities for market expansion and highlights on R&D.

KEY SPEAKERS:

• MILIND NARVEKAR, Senior Director Generic Regulatory Affairs, Teva Pharmaceuticals
• SHUBHADEEP SINHA, Vice-President & Head (Global)- Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs
• RAVISHANKAR KASTURI, Vice President - Development & Manufacturing, Reliance Life Sciences
• BINDU AJIT, Program Director, Biocon Academy
• HANMANT BARKATE, Vice President & Head Medical affairs & Clinical Research, Wockhardt
• SAMIR KULKARNI, Independent Biosimilars Professional Expert
• KIRAN KALAVADIA, Vice President, Cipla
• ANIL KUKREJA, Medical Director, Roche Pharmaceuticals
• LALIT LAKHWANI, Associate Director and Head of Clinical strategy, Dr. Reddy's Laboratories
• ANITA KRISHNAN, Assistant Director, Head Bioanalytical Team, Lupin
• SONIKA SHAH. Regulatory Affairs Head. Amgen
• VIJAY NAG THOTA, Head-Quality & Regulatory, SciGen BioPharma
• ALAP GANDHI, Head, Medical Affairs, Glaxo Smith Kline (GSK)
• KARAN THAKKAR, Regional Clinical Site Lead, Pfizer
• ROSHAN PAWAR, Senior Medical Advisor, Oncology, Alkem Laboratories
• SRIVANI MUKKAMALA, Independent Consultant
• PRASHANT BODHE, Director, CliniSearch

WHO SHOULD ATTEND:

CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property,Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science,Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs

CONFERENCE REGISTRATION PROCESSS:

You can e-mail your interest to Kavitha@virtueinsight.co.in OR Tel- +91 44 64998743

• Early Bird Discounted Price (Until 24th October 2017) –- (INR 6,000 + GST (18%) per delegate)
• Standard Price (25th October 2017 Onwards) – (INR 7,000 + GST (18%) per delegate)
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + GST (18%) per delegate)
• Group Discounts – 5 and above Delegates - (INR 6,000 + GST (18%) per delegate)
• Spot Registration on the day of the Conference -(INR 8,000 + GST (18%) per delegate)
• Conference Sponsor & Exhibition Stall or a paid Speaker Slots are also available.

In order to register you can simply e-mail me your invoice details in the below mentioned format;
E-mail- Kavitha@virtueinsight.co.in
• Name:
• GST Number (If Applicable):
• Company Name & Address:
• Job Position:
• Contact Number:

Join us to explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market and effectively bring these programs to market.

Related Resources

IJBES 2017   International Journal of Biomedical Engineering and Science
12th BSC 2018   12th Biosimilars Congregation 2018
ICACR 2018   2018 2nd International Conference on Automation, Control and Robotics (ICACR 2018)
ICBET--Ei and Scopus 2018   2018 8th International Conference on Biomedical Engineering and Technology (ICBET 2018)--Ei Compendex and Scopus
ICMHI--ACM, Ei and Scopus 2018   ACM--2018 2nd International Conference on Medical and Health Informatics (ICMHI 2018)--Ei Compendex and Scopus
ICHSM--ACM, Ei and Scopus 2018   ACM--2018 International Conference on Healthcare Service Management (ICHSM 2018)--Ei Compendex and Scopus
ICPPS--SCOPUS, Elsevier 2018   2018 3rd International Conference on Pharmacy and Pharmaceutical Science (ICPPS 2018)--SCOPUS, Elsevier
15th PHV 2018   15th Pharmacovigilance 2018